Acidic pH induces topoisomerase II-mediated DNA damage
- PMID: 12692309
- PMCID: PMC154323
- DOI: 10.1073/pnas.0935978100
Acidic pH induces topoisomerase II-mediated DNA damage
Abstract
Acidic pH plays an important role in various pathophysiological states and has been demonstrated to be carcinogenic in animal models. Recent studies have also implicated acidic pH in the development of preneoplastic Barrett's esophagus in human. However, little is known about the molecular mechanism underlying acidic pH-induced carcinogenesis. In the current study, we show that acidic pH, like the topoisomerase II (TOP2) poison VP-16 (demethylepipodophyllotoxin ethylidene-beta-D-glucoside), induces tumors in 9,10-dimethyl-1,2-benzanthracene(DMBA)-initiated mice. The following studies in tissue culture models have suggested that acidic pH acts like a TOP2 poison to induce TOP2-mediated DNA damage: (i) acidic pH induces TOP2-dependent DNA damage signals as evidenced by up-regulation of p53 and Ser-139 phosphorylation of H2AX [a substrate for ataxia telangiectasia mutated (ATM)ATM and Rad3-related (ATR) kinases]; (ii) acidic pH-induced cytotoxicity in tumor cells is reduced in TOP2-deficient cells; (iii) acidic pH increases the mutation frequency of the hypoxanthine phosphoribosyl transferase (HPRT) gene in a TOP2-dependent manner; and (iv) acidic pH induces reversible TOP2-mediated DNA strand breaks in vitro. We discuss the possibility that TOP2-mediated DNA damage may contribute to acidic pH-induced carcinogenesis.
Figures
Similar articles
-
Topoisomerase II-mediated DNA cleavage and mutagenesis activated by nitric oxide underlie the inflammation-associated tumorigenesis.Antioxid Redox Signal. 2013 Apr 1;18(10):1129-40. doi: 10.1089/ars.2012.4620. Epub 2012 Nov 23. Antioxid Redox Signal. 2013. PMID: 22998676
-
The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway.Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3239-44. doi: 10.1073/pnas.0736401100. Epub 2003 Mar 10. Proc Natl Acad Sci U S A. 2003. PMID: 12629207 Free PMC article.
-
Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.Cancer Sci. 2013 Feb;104(2):178-84. doi: 10.1111/cas.12067. Epub 2013 Jan 13. Cancer Sci. 2013. PMID: 23163762 Free PMC article.
-
Mechanisms to Repair Stalled Topoisomerase II-DNA Covalent Complexes.Mol Pharmacol. 2022 Jan;101(1):24-32. doi: 10.1124/molpharm.121.000374. Epub 2021 Oct 23. Mol Pharmacol. 2022. PMID: 34689119 Review.
-
Type II DNA Topoisomerases Cause Spontaneous Double-Strand Breaks in Genomic DNA.Genes (Basel). 2019 Oct 30;10(11):868. doi: 10.3390/genes10110868. Genes (Basel). 2019. PMID: 31671674 Free PMC article. Review.
Cited by
-
Human topoisomerases and their roles in genome stability and organization.Nat Rev Mol Cell Biol. 2022 Jun;23(6):407-427. doi: 10.1038/s41580-022-00452-3. Epub 2022 Feb 28. Nat Rev Mol Cell Biol. 2022. PMID: 35228717 Free PMC article. Review.
-
In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks.Cancer Res. 2009 Dec 1;69(23):9083-9. doi: 10.1158/0008-5472.CAN-09-2518. Epub 2009 Nov 17. Cancer Res. 2009. PMID: 19920191 Free PMC article.
-
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11014-9. doi: 10.1073/pnas.0704002104. Epub 2007 Jun 19. Proc Natl Acad Sci U S A. 2007. PMID: 17578914 Free PMC article.
-
A translational program that suppresses metabolism to shield the genome.Nat Commun. 2020 Nov 13;11(1):5755. doi: 10.1038/s41467-020-19602-2. Nat Commun. 2020. PMID: 33188200 Free PMC article.
-
H2A.X Phosphorylation in Oxidative Stress and Risk Assessment in Plasma Medicine.Oxid Med Cell Longev. 2021 Dec 13;2021:2060986. doi: 10.1155/2021/2060986. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34938381 Free PMC article. Review.
References
-
- Williams A C, Collard T J, Paraskeva C. Oncogene. 1999;18:3199–3204. - PubMed
-
- Yamamoto D, Kiyozuka Y, Uemura Y, Yamamoto C, Takemoto H, Hirata H, Tanaka K, Hioki K, Tsubura A. J Cancer Res Clin Oncol. 2000;126:191–197. - PubMed
-
- Chevfec G, Schnell T, Sontag S. Am J Clin Pathol. 1992;98:5–7. - PubMed
-
- Shaheen N, Ransohoff D F. J Am Med Assoc. 2002;287:1972–1981. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous